Jennifer Anne Krajewski MD (She/Her)

Pediatric Hematology & Oncology•Madison, NJ

Pediatric Hematologic Oncology

Pediatric Clinical Development Lead

Bristol Myers Squibb5 Giralda FarmsMadison, NJ 07940
Phone+1 202-321-4531

Dr. Krajewski is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krajewski's full profile Already have an account?

Summary

Dr. Krajewski joined BMS in 2023, and is the pediatric clinical development lead, helping bring cutting edge treatment to children. She was the clinical director of peds BMT at Westchester MC and was a peds BMT attending at HackensackUMC. She received her MD from Chicago Med, completed pediatric residency at Children's National, and completed fellowship in peds heme/onc at Columbia University.

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Hematology/Oncology, 2006 - 2009
Children's National HospitalResidency, Pediatrics, 2003 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003
University of MichiganB.S., Biology & Biopsychology, Magna Cum Laude, 1995 - 1999

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NJ State Medical License 2010 - 2025
NY State Medical License 2006 - 2023
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Merit Award American Society of Clinical Oncology (ASCO), 2011
Attending of the Year Hackensack University Medical Center, 2011
Best Translational Research Project Columbia University, 2009

Clinical Trials

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
COMPLETED
PHASE3
Abatacept as GVHD Prophylaxis Phase 2 Start of enrollment: 2013 Feb 01
COMPLETED
PHASE2
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
COMPLETED
PHASE2

Publications & Presentations

PubMed

6 citations
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy.
Niketa C Shah, Alexander Ngwube, Tara Suresh, Anna Sowa, Allistair Abraham
Transplantation and Cellular Therapy. 2025-10-01
4 citations
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.
Christopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan
Blood Advances. 2023-07-11
10 citations
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report.
Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano
Journal for Immunotherapy of Cancer. 2023-01-01

Journal Articles

The Safety and Efficacy of Clofarabine in Combination with High-Dose Cytarabine and Total Body Irradiation Myeloablative Conditioning and Allogeneic Stem Cell Transpla...
Stacey Zahler, Mitchell S Cairo, Jennifer Krajewski, M Fevzi Ozkaynak, Alexandra C Cheerva, Theodore B Moore, Alfred P Gillio, Mark C Walters, Nature
Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease
Ender KL, Krajewski JA, Babineau J, Tregallo M, Schechter W, Saroyan JM, Kharbanda A, Pediatr Blood Cancer, 1/19/2013
Pulmonary Thromboembolism in a Child with Sickle Cell Hemoglobin D Disease in the Setting of Acute Chest Syndrome
Hazel Villanueva, Sandeepkumar Kuril, Jennifer Krajewski, and Aziza Sedrak, Case Reports in Pediatrics, 1/1/2013

Abstracts/Posters

Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell T...
Krajewski J, Radhakrishnan K, Chen N, Ricci A, Geyer M, Harrison L, Ozkaynak MF, Satwani P, Cheerva A, Talano J, Moore T, Gillio AP, Baxter-Lowe LA, Cairo MS, Tandem annual meeting, 1/1/2013
Improvement in Acute Management of Vaso-occlusive Pain in Pediatric Sickle Cell Disease with Use of a Clinical Pathway
Ender K, Freed J, Babineau J, Tresgallo M, Schechter W, Saroyan J, Kharbanda A, American Society of Hematology annual meeting, 1/1/2010
Acute Management of Vaso-Occlusive Pain in Pediatric Sickle Cell Disease
Freed J, Ender, K, American Society of Pediatric Hematology/Oncology annual meeting, 1/1/2009